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Extensive skin defect represents a real problem and major challenge in plastic and reconstructive surgery. On one hand, skin grafts
offer a practical method to deal with skin defects despite their unsuitability for several complicated wounds. On the other hand,
negative pressure wound therapy (NPWT), applied before skin grafting, promotes granulation tissue growth. The aim of the study
is to evaluate the improvement in wound healing given by the merger of these two different approaches. We treated 23 patients
for large wounds of multiple factors. Of these, 15 were treated with the application of V.A.C. Therapy (KCI Medical S.r.l., Milan,
Italy), in combination with skin grafts after a prior unsuccessful treatment of 4 weeks with mesh skin grafts and dressings. Another
8 were treated with only mesh skin graft. Pain reduction and wound area reduction were found statistically significant (𝑝 < 0.0009,
𝑝 < 0.0001). Infection was resolved in almost all patients. According to our study, the use of the negative pressure wound therapy
over mesh skin grafts is significantly effective especially in wounds resistant to conventional therapies, thereby improving the rate
of skin graft take.
1. Introduction
Chronic wounds, which typically result from medical con-
ditions, nutritional deficiencies, infections, and metabolic
disorders, involve intensive and time-consuming treatments
[1]. Extensive skin defect is a great challenge and a major
problem in plastic and reconstructive surgery.The use of skin
grafts, whether split thickness or full thickness, has offered a
reasonablemethod to address this problem.However the sole
use of skin autologous grafts in complicated woundsmight be
not entirely satisfactory [1].
Negative pressure wound therapy (NPWT) is a thera-
peutic technique, which facilitates the healing of acute and
chronic wounds [1]. NPWT, which deters the accumulation
of fluid at wound sites through continuous drainage, makes
daily dressing changes unnecessary, improves regional blood
flow, and reduces bacterial proliferation, thus reducing the
chances of infection [1]. NPWT can be successfully used
before skin grafting, promoting granulation tissue growth
with a 54% increase in growth rate and improving the survival
rate of free skin graft [2–6].
The aim of the study is to evaluate the improvement in
wound healing given by the merger of these two different
approaches. Thereby the study underlines the crucial role of
NPWT applied not only before but also on top of skin grafts.
Our clinical study compares application of V.A.C. Therapy
(KCI Medical S.r.l, Milan, Italy) in combination with skin
grafts to repair acute and chronic wounds with the treatment
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Figure 1: 50-year-old patient affected by shoulder sarcoma after tumor excision and reconstruction with pedicled latissimus dorsi flap and
skin grafts. (A) Seven days after surgery skin grafts and superficial latissimus dorsi flap necrosis due to Pseudomonas aeruginosa infection. (B)
Area 21 days after surgical debridement and NPWT. Cultural examinations of wound continued to be positive for Pseudomonas aeruginosa.
2. Material/Patients and Methods
The study took place from January 2014 to June 2015 in
the Department of Plastic and Reconstructive Surgery of
“Sapienza” University of Rome.
A group of 23 patients were treated for large wounds of
multiple factors. Of these 15 were treated with the application
of V.A.C.Therapy (KCI Medical S.r.l, Milan, Italy), in combi-
nation with skin grafts after a prior unsuccessful treatment of
4 weeks with mesh skin grafts and dressing. Another 8 were
treated with the only mesh skin graft. Inclusion criteria were
wound area > 70 cm2. Exclusion criteria were patients with
diabetes mellitus, patients treated with corticosteroids, and
uncollaborative patients. Treatment was carried out on all by
the same team.
A prospective-comparative study between mesh skin
graft (SG) and mesh skin graft plus NPWT (SG+) was
carried out evaluating several objective and subjective data
before and after treatments on the same patient. The data
collected before the first and the second treatment were
disease duration, presence of pain, and wound characteristics
such as size, exudation, and pain. In addition, a bacterial
culture and sensitivity were performed for all the patients at
the beginning of the treatment; after two weeks of SG; after
4 weeks; at the end of the first phase; and after two weeks of
SG+. Before surgery, photos were made for every candidate.
All patients underwent the same surgical protocol: in
the first period, a mesh skin graft was placed and treated
in traditional way (wet gauze application and compression).
Whenever mesh skin grafts failed (4 weeks after surgery)
the innovative surgical protocol was applied: wound dis-
infection with chlorine-based disinfectant and povidone-
iodine, washing with saline solution, and application of mesh
skin grafts. In addition NPWT was placed over the wet
gauze for compression and immobilization. NPWT was set
at −75mmHg of aspiration. After five days the dressing was
changed for a first evaluation of engraftment. NPWT was in
place until grafts were engrafted and no more exudation was
present (Figures 1–5(b)).
After 4 weeks of treatment (either SG and SG+) results
were evaluated taking into account wound area (assessed as
an ellipsoid) [7], status of the grafts, cultural examination,
and pain relief. In order to describe subjective pain sensation,
visual analogic scale (VAS) was submitted to the patients
at the start of the treatment and on a weekly basis during
the 2-month study period. A range from 1 (no pain) to
10 (maximum pain level) was considered. Wound margins
were evaluated for necrosis, dermatitis, or, on the contrary,
full integrity; periwound skin was evaluated for erythema,
edema, and full integrity. Pain relief and area reduction were
compared and analyzed using Student’s t-test in two groups.
3. Results
Of the 23 patients treated in this study, 14 were males and 9
were females. Epidemiological data showed an average of 52
years (between 19 and 87 years). Etiologies were manifold: 15
had chronic vascular wound and 8 posttraumatic ulcers. In
the first 4 weeks of treatment, complete healing occurred in 8
patients.
Complete healing occurred in 14 patients over a period of
10 weeks (6 of SG+). Complete initial engraftment occurred
in 12 patients over a period of 8 weeks (4 of SG+). Only 1
patient was partially responsive to both treatments. In any
case a remarkable reduction in wound exudation, edema,
and perilesional margins was registered. Pain reduction was
significant during the first period in 8 patients (average reduc-
tion of 1 point in the first week and 2.3 points at the end of
the fourth week), the same ones whose wounds healed at the
end of the fourth week. Pain reduction was significant in the
second period in all patients not healed (15), with an average
reduction of 2.1 points in the first week and 4 after 6 weeks.
An interesting trend was highlighted in the 15 patients
entered in the second stage of therapy. In fact in the first 4
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Figure 2: Surgical time. (A) Mesh skin grafts were placed over the wound and fixed; (B) placement of wet gauzes; (C) placement of NPWT;
(D) negative pressure activation at −75mmHg.
Figure 3: Postoperative results. (A) Anterior view 3 months after surgery; (B) lateral view 3 months after surgery with no signs of infection.
weeks of treatment only an average pain reduction of 1.04
points was reported, quite insignificant in comparison with
the 2.13-point reduction after the first week of SG+ treatment
(𝑝 < 0.0047). Another interesting piece of data was the
comparison between pain relief after the first phase (mean =
3.39) and the second phase (mean = 6.13) with a 𝑝 < 0.0009
(Tables 1 and 2).
Taking into account the second analyzed parameter,
wound area reduction, significant results were found (𝑝 <
0.0001, 𝑡 = 4.66); a mean reduction of 40.5%was found in the
first period in comparison with 96.3% in the second period
(Tables 3 and 4).
Cultural examinations of wound exudates at time 0
showed 8 patients positive for Staphylococcus aureus, 2 for
Pseudomonas aeruginosa, and 1 forEnterococcus faecalis. After
two weeks of SG, 7 patients were positive for Staphylococcus
aureus, 2 for Pseudomonas aeruginosa, and 1 for Enterococcus
faecalis. After 4 weeks Staphylococcus aureus was present
in 5 patients, Pseudomonas aeruginosa in 2 patients, and
Enterococcus faecalis in 1 patient. Cultural examinations were
repeated after 2 weeks of SG+ and shown the presence
of Staphylococcus aureus in 2 patients and Pseudomonas
aeruginosa in 1 patient (Table 5).
4. Discussion
Chronic ulcer usually means an injury neither spontaneously
evolving towards healing nor progressing through normal
stages of healing such as inflammation, proliferation, and
remodeling. This condition represents a serious physical and
psychological limit to the patient as well as being a burden for
the health system [7].
Treatments in patients with chronic wounds usually con-
sist in debridement and skin grafts. An important innovation
in chronic wounds management is the use of NPWT over
the skin graft. Our advice would be a trick we developed:
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Figure 4: 45-year-old patient affected by chronic infected lower limb ulcer. (A) Recovery time (cultural examinations were positive for
Pseudomonas aeruginosa and Enterococcus faecalis); (B) after surgical debridement and antibiotic therapy (cultural examination was positive
for Pseudomonas aeruginosa); (C) 7 days after meshed skin graft with NPWT; (D) 1 month after surgery.
(a) (b)
Figure 5: (a) 73-year-old patient after road accident with tram. She presented bilateral skin degloving of the lower limb. The patients
underwent reconstruction with mesh skin grafts in traditional way for three times. This technique failed due to infection so the patient
underwent reconstruction with our innovative protocol (mesh skin grafts + NPWT): (a) recovery time; (b) 1-year follow-up.
use 75mmHg negative pressure on the skin graft instead
of 125mmHg. In our experience this is very important
in order to allow good adhesion of the skin graft to the
wound bed during initial engraftment. We evaluated the data
reported and highlighted a marked and statistically signifi-
cant improvement in the treatment of large loss of substance
throughmesh skin grafts dressed with V.A.C.Therapy system
(𝑝 < 0.001). In fact, taking into account the 23 patients
enrolled in the study, it was pointed out that only 8 of them
healed through traditional treatment, while the remaining 14
out of 15 healedwith themodified treatment in 6weeks.These
data provide us with various interpretations: the 15 patients
who remained in the study were those who had a wound
whose healing was trickier. It is also interesting to evaluate
how the data “pain relief” strongly and quickly improved (in
a statistically significant way) already after the first week of
BioMed Research International 5
Table 1: Pain relief in patients during 10 weeks valued with VAS.
Patient Time 0 1 week 4 weeks 5 weeks 6 weeks Pain
1 7 −3 −4 — — 0
2 6 −2 −4 — — 0
3 7 −1 −6 — — 0
4 8 −2 −6 — — 0
5 6 −3 −3 — — 0
6 7 −1 −6 — — 0
7 8 −3 −5 — — 0
8 6 −3 −3 — — 0
9 7 −1 −1 −1 −4 0
10 8 +1 −1 −3 −5 0
11 8 −1 −1 −1 −5 0
12 8 −1 −1 −2 −4 0
13 7 −1 −1 −2 −3 0
14 7 0 −1 −3 −5 0
15 6 0 −2 −1 −3 0
16 8 −1 −2 −3 −2 0
17 8 0 −1 −3 −4 0
18 7 −1 −1 −2 −3 0
19 8 −2 −1 −1 −4 0
20 7 +1 −2 −2 −4 0
21 9 0 0 −3 −5 5
22 8 0 −1 −2 −5 0
23 6 0 −1 −3 −4 0
Mean 7.26 −1.04 −2.3 −2.1 −4
Table 2: Statistical analysis of data collected.
(a) Comparison of pain relief in week 1 and week 5




2.13 <0.0047 −1.82/−0.36 36 0.361 3.015
(b) Comparison of pain relief in week 4 and week 10




4.0 <0.0035 −2.72/−0.58 36 0.528 3.127
(c) Comparison of pain relief in first treatment (SG) and second treatment
(SG+)




6.13 <0.0009 −4.29/−1.2 36 0.761 3.6
SG+ treatment in the group of patientswho had reported only
a marginal improvement in the first phase of the study.
Another important fact to consider is the presence of
infection in the examination cultures after 4weeks (end of the
first phase of treatment) in comparison with the examination
carried out after 6 weeks. In fact after 4 weeks 5 people
reported positive culture examination for S. aureus infection,
2 P. aeruginosa, and 1 E. faecalis; after only 2 weeks of treat-
ment with SG+NPWT only 2 people still had positive wound
swab for S. aureus and 1 P. aeruginosa. We observed also an
improvement of the other signs and symptoms of infection
Table 3: Comparison between area reduction (AR) in two phases of
the study (SG, SG+).
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Table 4: Statistical analysis of the area reduction values.




96.3 <0.0001 −80.08/−31.54 36 11.969 4.66
𝑁 = number of patients, M = mean, 𝑝 = 𝑝 value, 95% ci = 95% confidence
interval, df = degree of freedom, sed = standard error of difference, and 𝑡 = 𝑡
value.
Table 5: Cultural examination, time 0, after 2 weeks, after 4 weeks,
and after 6 weeks.
Patient Time 0 2 weeks 4 weeks 6 weeks
1 — — — —
2 — — — —
3 SA SA — —
4 SA — — —
5 — — — —
6 SA SA — —
7 — — — —
8 — — — —
9 — SA SA —
10 — — — —
11 SA — — —
12 EF EF EF —
13 — SA SA —
14 SA SA SA SA
15 — — — —
16 SA — — —
17 — — — —
18 PA PA PA —
19 SA SA SA SA
20 — — — —
21 PA PA PA PA
22 — — — —
23 SA SA SA —
SA = Staphylococcus aureus; PA = Pseudomonas aeruginosa; EF = Enterococ-
cus faecalis.
as purulent discharge from the wound, pain, swelling, and
redness. With the data available we can say that the use of
NPWT above mesh skin grafts is significantly better than the
mesh skin grafts alone. In addition it showed a faster recovery
and a better dressing management and a reduced number of
dressing changes. Numerous studies have been carried out
on the combined use of NPWT over dermal substitutes also
to cover large and deep wounds (including bone and tendon
exposure) [7–13]. Every study assessed that, thanks to the
integrated use of these techniques, the preparation of the
wound bed was quicker in order to obtain a better graft take
[14]. In fact NPWT used over the dermal template delivered
a faster maturation (approximately 1-2 weeks) and a higher
integration quality [15, 16]. This integrated technique keeps
the matrix immobilized, leaves the wound bedmoist and free
of debris, prevents the accumulation of fluid collections, and
reduces bacterial colonization of the wound [13]. Likewise
biological semipermeable membranes, connected through
drainage tubes to vacuum source, create a fully closed neg-
ative pressure drainage condition promoting the expulsion of
effusion and liquefied necrotic tissue in the cavities [17]. This
kind of dressing results in a better immobilization of the graft,
thereby limiting shear forces, eliminating fluid collections,
bridging of the graft, and decreasing bacterial contamination.
5. Conclusion
According to our study the use of the negative pressure
wound therapy over mesh skin grafts is dramatically effective
especially in wounds resistant to conventional therapies.
Although there are no current studies on the two techniques
combined, our data are comparable to those on the integra-
tion of dermal substitutes and NPWT.
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